TW200611895A - Process for preparing diphenylazetidinone derivatives - Google Patents

Process for preparing diphenylazetidinone derivatives

Info

Publication number
TW200611895A
TW200611895A TW094116388A TW94116388A TW200611895A TW 200611895 A TW200611895 A TW 200611895A TW 094116388 A TW094116388 A TW 094116388A TW 94116388 A TW94116388 A TW 94116388A TW 200611895 A TW200611895 A TW 200611895A
Authority
TW
Taiwan
Prior art keywords
oalkyl
formula
mch2oh
integers
substituents
Prior art date
Application number
TW094116388A
Other languages
English (en)
Inventor
Heiner Jendralla
Guenter Billen
Wendelin Frick
Bernd Junker
Theodor Andreas Wollmann
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of TW200611895A publication Critical patent/TW200611895A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TW094116388A 2004-05-21 2005-05-20 Process for preparing diphenylazetidinone derivatives TW200611895A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004025072A DE102004025072A1 (de) 2004-05-21 2004-05-21 Verfahren zur Herstellung von Diphenyl-azetidinon-Derivaten

Publications (1)

Publication Number Publication Date
TW200611895A true TW200611895A (en) 2006-04-16

Family

ID=34968088

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094116388A TW200611895A (en) 2004-05-21 2005-05-20 Process for preparing diphenylazetidinone derivatives

Country Status (13)

Country Link
US (1) US7563888B2 (zh)
EP (1) EP1753717A1 (zh)
JP (1) JP2007538041A (zh)
CN (1) CN100582092C (zh)
AR (1) AR049283A1 (zh)
AU (1) AU2005245123A1 (zh)
CA (1) CA2567481A1 (zh)
DE (1) DE102004025072A1 (zh)
IL (1) IL178993A0 (zh)
MX (1) MXPA06013258A (zh)
TW (1) TW200611895A (zh)
UY (1) UY28913A1 (zh)
WO (1) WO2005113495A1 (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE50111751D1 (de) * 2000-12-21 2007-02-08 Sanofi Aventis Deutschland Neue diphenzylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung zur behandlung von lipidstoffwechselstörungen
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
EP1699759B1 (en) 2003-12-23 2010-10-20 AstraZeneca AB Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
UY29607A1 (es) 2005-06-20 2007-01-31 Astrazeneca Ab Compuestos quimicos
AR057072A1 (es) 2005-06-22 2007-11-14 Astrazeneca Ab Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
AR060623A1 (es) 2006-04-27 2008-07-02 Astrazeneca Ab Compuestos derivados de 2-azetidinona y un metodo de preparacion
JP5059355B2 (ja) * 2006-08-01 2012-10-24 壽製薬株式会社 オキサゾリジン誘導体の製造方法
CZ302395B6 (cs) * 2007-03-02 2011-04-27 Zentiva, A. S. Zpusob výroby (3R,4S)-1-(4-fluorfenyl)-3-[(3S)-3-(4-fluorfenyl)-3-hydroxypropyl)]-4-(4-hydroxyfenyl)-2-azetidinonu
CA2675312A1 (en) 2007-03-06 2008-09-12 Teijin Pharma Limited 1-biarylazetidinone derivative
US20090047716A1 (en) * 2007-06-07 2009-02-19 Nurit Perlman Reduction processes for the preparation of ezetimibe
DE102007054497B3 (de) * 2007-11-13 2009-07-23 Sanofi-Aventis Deutschland Gmbh Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung
US9388440B2 (en) 2009-04-01 2016-07-12 Mylan Laboratories Limited Enzymatic process for the preparation of (S)-5-(4-fluoro-phenyl)-5-hydroxy-1morpholin-4-yl-pentan-1-one, an intermediate of Ezetimibe and further conversion to Ezetimibe
WO2015039675A1 (en) 2013-09-23 2015-03-26 Pharmathen S.A. Novel process for the preparation of ezetimibe intermediates

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT67341A (en) * 1991-07-23 1995-03-28 Schering Corp Substituted beta-lactam compounds useful as hypocholesterolemic agents, pharmaceutical compositions containing the same and process for the production thereof

Also Published As

Publication number Publication date
AR049283A1 (es) 2006-07-12
US7563888B2 (en) 2009-07-21
IL178993A0 (en) 2007-03-08
CA2567481A1 (en) 2005-12-01
EP1753717A1 (de) 2007-02-21
UY28913A1 (es) 2005-12-30
AU2005245123A1 (en) 2005-12-01
CN100582092C (zh) 2010-01-20
DE102004025072A1 (de) 2005-12-15
MXPA06013258A (es) 2007-02-28
CN1956951A (zh) 2007-05-02
US20070149501A1 (en) 2007-06-28
WO2005113495A1 (de) 2005-12-01
JP2007538041A (ja) 2007-12-27

Similar Documents

Publication Publication Date Title
TW200611895A (en) Process for preparing diphenylazetidinone derivatives
MX2012009076A (es) Composiciones de combustible.
MX2010012199A (es) Compuesto de cromeno.
AR043461A1 (es) Proceso para la manufactura de mercaptosilanos en bloque
MY160745A (en) A gasoline composition comprising one or more quaternary ammonium salt additives, and methods and uses thereto
NO20075864L (no) Fremgangsmate for fremstilling av polyoksymetylen dialkyletere fra trioksan og dialkyletere
RU2009105669A (ru) Способ получения 3-замещенных 2-амино-5-галогенбензамидов
MY138113A (en) Mercaptosilanes
DE602005022619D1 (de) Verfahren zur herstellung von valsartan
EP2149587A4 (en) POLYCARBONATE RESIN AND METHOD FOR PRODUCING THE SAME
NO20072198L (no) Korrosjons- og gasshydratinhibitorer med foroket biologisk nedbrytbarhet og redusert toksisitet
BRPI0407951A (pt) composição polimérica
GB0501964D0 (en) Chemical compounds
MXPA04001682A (es) Inhibidores de corrosion e hidratos de gas que tiene mejor solubilidad en agua y mayor biodegradabilidad.
FI812183L (fi) 3,1-benzoxazin-2-oner deras framstaellning och anvaendning
RU2009112286A (ru) Полиолефиновая композиция со сниженной миграцией
ATE527228T1 (de) Verfahren zur herstellung von beta-santalol und derivaten davon
DE69616719D1 (de) Verfahren zur herstellung von taxol und seiner derivate
EA200300458A1 (ru) Новые соединения аминотриазолона, способ их получения и фармацевтические композиции, содержащие их
ATE416178T1 (de) Verbindungen enthaltend 3,4-methylendioxythiopen- einheiten
DE602007002639D1 (de) Neuartige epoxidverbindungen und verfahren zu ihrer herstellung
NO20093328L (no) Tilsetningsstoffer for oljeutvinning fra reservoarer
CY1105972T1 (el) ΝΕΑ ΥΠΟΚΑΤΕΣΤΗΜΕΝΑ ΠΑΡΑΓΩΓΑ [1,4] ΒΕΝΖΟΔΙΟΞΙΝΟ [2,3-e] ΙΣΟΪΝΔΟΛΙΟΥ, ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΑΥΤΩΝ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΑ ΠEPΙΕΧΟΥΝ
CA2504418A1 (en) Process for preparing palladium(0) compounds
WO2006079719A3 (fr) Nouveaux derives d'oximes heterocycliques, leur procede de preparation, les compositions pharmaceutiques qui les contiennent et leur utilisation pour le traitement de l’obesite